CAS: 2904682-19-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | N-((4-(Benzo[d]oxazol-2-yl)phenyl)carbamothioyl)-2-naphthamide REF: IN-DA029HKZCAS: 2904682-19-3 | 95% | To inquire | Tue 12 Nov 24 |
 | PDS-0330 REF: TM-T73593CAS: 2904682-19-3 | 99.93% | 90.00 €~2,205.00 € | Wed 13 Nov 24 |
N-((4-(Benzo[d]oxazol-2-yl)phenyl)carbamothioyl)-2-naphthamide
CAS:2904682-19-3
Formula:
C25H17N3O2S
Purity:
95%
Molecular weight:
423.4864
Ref: IN-DA029HKZ
| 1mg | 130.00 € | ||
| 5mg | 273.00 € | ||
| 10mg | 614.00 € | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 12 Nov 2024
PDS-0330
CAS:2904682-19-3
PDS-0330, a claudin-1 inhibitor, hinders CRC growth and metastasis with micromolar affinity and promising pharmacokinetics.
Formula:
C25H17N3O2S
Purity:
99.93%
Color and Shape:
Soild
Molecular weight:
423.49
Ref: TM-T73593
| 1mg | 90.00 € | ||
| 5mg | 184.00 € | ||
| 10mg | 305.00 € | ||
| 25mg | 550.00 € | ||
| 50mg | 794.00 € | ||
| 100mg | 1,099.00 € | ||
| 500mg | 2,205.00 € |
Estimated delivery in United States, on Wednesday 13 Nov 2024
